(Q53597473)

16 May 2018

title

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. (English)

1 reference

16 May 2018

1 reference

4

Hedvig Hricak

1 reference

16 May 2018

Aliya Qayyum

1

1 reference

16 May 2018

Fergus V Coakley

2

1 reference

16 May 2018

Antonio C Westphalen

3

1 reference

16 May 2018

William T Okuno

5

1 reference

16 May 2018

Bethan Powell

6

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 February 2005

1 reference

16 May 2018

published in

Gynecologic Oncology

1 reference

16 May 2018

volume

96

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

301-306

1 reference

16 May 2018

Cancer in older persons. Magnitude of the problem--how do we apply what we know?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Staging ovarian cancer: role of imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Peritoneal metastases: detection with spiral CT in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Ovarian cancer: staging with CT and MR imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Ovarian carcinoma: value of CT in predicting success of debulking surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Can pre-operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Imaging of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Neoadjuvant chemotherapy for advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Cytoreductive surgery for the management of stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

Patterns of care for women with ovarian cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.054

10.1016/J.YGYNO.2004.06.054

7 January 2021

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018